Prothena (PRTA) Fundamental Analysis: Revenue, Earnings & Valuation

3.32 / 10

Netural

Fundamental rating is Neutral with a 3.3/10 strength. Revenue‑MV and Profit‑MV are positive, but low Current and Fixed assets turnover drag performance. Overall fund score 3.32 reflects constrained investment potential.

Analysis Checks(7/10)

Revenue-MV

Value-8.26

Score2/3

Weight18.01%

1M Return8.05%

Inventory turnover ratio

Value106.57

Score3/3

Weight15.58%

1M Return6.65%

Gross profit margin (%)

Value100.00

Score2/3

Weight3.30%

1M Return1.67%

Profit-MV

Value0.68

Score2/3

Weight14.66%

1M Return6.36%

Income tax / Total profit (%)

Value-21.54

Score2/3

Weight1.84%

1M Return0.98%

Current assets turnover ratio

Value0.02

Score0/3

Weight-2.74%

1M Return-1.61%

Fixed assets turnover ratio

Value0.81

Score1/3

Weight-1.91%

1M Return-1.13%

Cost of sales ratio (%)

Value57.03

Score3/3

Weight7.74%

1M Return4.08%

Asset-MV

Value-0.55

Score1/3

Weight29.15%

1M Return11.48%

Cash-MV

Value0.03

Score2/3

Weight14.36%

1M Return6.19%

Is PRTA undervalued or overvalued?

PRTA scores 3.32/10 on fundamentals and holds a Fair valuation at present. Backed by its -63.62% ROE, -2520.57% net margin, -2.10 P/E ratio, 1.83 P/B ratio, and -99.56% earnings growth, these metrics solidify its Netural investment rating.